BMI Test for Women: Results and Health Checks

A BMI test for women is a widely used screening tool that estimates whether body weight falls within a healthy range based on height and weight. While BMI is quick and straightforward to calculate, it has important limitations for women, whose body composition, hormonal profile and health risks change across different life stages. This article explains how BMI is calculated, what the results mean, why the score can sometimes be misleading, and which additional health checks women should consider alongside their BMI result.

What is a BMI test and how does it work for women?

A BMI test divides weight in kilograms by height in metres squared to produce a score placed within NHS categories: underweight, healthy weight, overweight or obese. It is a population-level screening tool, not a diagnostic measure, and does not directly measure body fat.

A BMI test is a simple screening calculation that uses a person's height and weight to produce a numerical score, which is then compared against population-based reference ranges to indicate whether body weight falls within a healthy range. BMI stands for Body Mass Index, and it was originally developed as a population-level statistical tool rather than a diagnostic measure for individuals. Despite its limitations, it remains widely used in UK clinical practice because it is quick, inexpensive and requires no specialist equipment.

For women, the calculation works in exactly the same way as it does for men: weight in kilograms is divided by height in metres squared. The resulting number is then placed within one of four standard categories used by the NHS: underweight, healthy weight, overweight or obese. These categories are based on data from large population studies and are intended to give a broad indication of health risk rather than a precise individual assessment.

It is worth noting that BMI does not directly measure body fat. Two women of identical height and weight can have very different body compositions, with one carrying more muscle and another carrying more fat, yet both would receive the same BMI score. For this reason, clinicians in the UK typically use BMI as one part of a broader health assessment rather than as a standalone diagnostic tool.

BMI categories are not applied in the same way during pregnancy. Antenatal care uses pre-pregnancy or booking weight for risk assessment, and weight loss should not be targeted during pregnancy unless specifically advised by a clinician. If you are pregnant or have recently given birth, speak to your midwife or GP about how your weight is being monitored.

NICE guidance and NHS clinical pathways use BMI thresholds to help identify eligibility for certain interventions, including weight management programmes and medicines. However, healthcare professionals are encouraged to interpret BMI results alongside other clinical information, particularly for women, whose body composition changes across different life stages.

How do you calculate your BMI as a woman in the UK?

Divide your weight in kilograms by your height in metres squared; for example, 70 kg divided by 1.65 m squared gives a BMI of approximately 25.7. The NHS provides a free online calculator, and results can be compared against standard adult categories.

To calculate your BMI, divide your weight in kilograms by your height in metres, then divide the result again by your height in metres. For example, a woman who weighs 70 kg and is 1.65 m tall would calculate: 70 divided by 1.65, which gives 42.4, then divided by 1.65 again, giving a BMI of approximately 25.7. The NHS provides a free BMI calculator on its website, which is a straightforward way to check your result without needing to do the arithmetic manually.

If you prefer to work in imperial measurements, you can convert your weight from stones and pounds to kilograms (1 stone equals approximately 6.35 kg) and your height from feet and inches to metres (1 inch equals approximately 0.0254 m) before applying the same formula. Many online tools, including those on NHS-affiliated websites, accept imperial inputs directly.

Once you have your BMI figure, you can compare it against the standard NHS adult categories:

• Below 18.5: Underweight

• 18.5 to 24.9: Healthy weight

• 25 to 29.9: Overweight

• 30 and above: Obese

For clinical purposes, obesity is further subdivided: class I (BMI 30 to 34.9), class II (BMI 35 to 39.9) and class III (BMI 40 and above). These subclasses are used in UK clinical pathways to guide decisions about treatment intensity and eligibility for specialist services.

For women from Black, Asian and minority ethnic backgrounds, NICE guidance notes that health risks associated with excess weight may occur at lower BMI thresholds. NICE describes these as risk thresholds rather than a redefinition of healthy weight: for people of South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family background, increased risk is associated from a BMI of around 23, and high risk from around 27.^[3][6]5. These are the same thresholds used in NICE clinical guidelines and are intended to prompt earlier assessment and discussion, not to replace the standard categories. If you are unsure which thresholds apply to you, your GP can advise based on your individual circumstances.

BMI should always be interpreted alongside other measures. Women who are very physically active or have a high proportion of lean muscle mass may have a BMI in the overweight range despite a healthy body composition. BMI categories are also not applied in the same way during pregnancy; speak to your midwife or GP if you have questions about weight during or after pregnancy.

What do your BMI results actually mean for your health?

A BMI outside the healthy range indicates increased risk of conditions such as type 2 diabetes, cardiovascular disease or osteoporosis, but does not confirm a diagnosis. A healthy BMI does not guarantee good health, and results should be interpreted alongside other clinical information.

A BMI result outside the healthy weight range is associated with an increased risk of certain health conditions, but it does not mean a diagnosis has been made or that a health problem is inevitable. For women with a BMI in the overweight or obese range, research consistently shows higher rates of type 2 diabetes, cardiovascular disease, certain cancers (including breast and endometrial cancer), sleep apnoea and joint problems.^[11][12] Conversely, a BMI below 18.5 is associated with increased risk of osteoporosis, nutritional deficiencies and, in women of reproductive age, menstrual irregularities and reduced fertility.

For women with a BMI of 30 or above, or 27.5 or above in certain ethnic groups, NICE guidance supports referral to structured weight management services. Access to NHS weight management services and prescription medicines depends not only on NICE guidance but also on national commissioning decisions and local Integrated Care Board (ICB) pathways, and is typically provided through specialist services rather than directly through a GP referral alone. Prescription medicines for weight management, such as semaglutide (Wegovy) or tirzepatide (Mounjaro), which is authorised by the MHRA for both type 2 diabetes and chronic weight management, may be considered by a prescriber where specific clinical criteria are met.^[8][9] Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight management consultations, with prescriber review and pharmacist support, where a medicine such as Mounjaro is one option a prescriber may consider if it is clinically appropriate.

There are some situations where you should seek prompt GP review rather than waiting for a routine appointment. These include unintentional weight loss (losing weight without trying), a BMI below 18.5 accompanied by symptoms such as persistent fatigue, dizziness or difficulty eating, any concerns about disordered eating or an eating disorder, or a BMI of 40 or above (or 35 or above with significant health conditions such as type 2 diabetes or high blood pressure). In these situations, early assessment is important.

It is equally important not to interpret a BMI within the healthy range as a guarantee of good health. Some women with a BMI between 18.5 and 24.9 may still carry excess visceral fat, have elevated blood pressure or cholesterol, or have other risk factors that are not captured by BMI alone. A healthy BMI result should be seen as reassuring but not as a reason to avoid other routine health checks. Your GP or practice nurse can help you understand what your result means in the context of your overall health.

Why can BMI be misleading for women?

BMI does not account for body composition, fat distribution or hormonal changes, meaning it can underestimate or overestimate health risk in women. Menopause-related fat redistribution towards the abdomen increases cardiometabolic risk even when overall BMI remains stable.

BMI can be misleading for women because it does not account for body composition, fat distribution, hormonal changes or life stage, all of which significantly influence health risk in ways that a single height-to-weight ratio cannot capture. A woman who exercises regularly and has a high proportion of lean muscle mass may register as overweight on the BMI scale despite having a low body fat percentage and excellent metabolic health. Conversely, a woman with a BMI in the healthy range but a high proportion of visceral (abdominal) fat may carry a greater cardiometabolic risk than her BMI suggests.

Hormonal changes across a woman's life, including puberty, pregnancy, the postnatal period and the menopause transition, alter body composition in ways that BMI does not reflect. During the menopause, many women experience a redistribution of fat from the hips and thighs towards the abdomen. This shift in fat distribution is associated with increased cardiovascular and metabolic risk even when overall weight remains stable, and it would not be detected by a BMI calculation alone.

Ethnicity also affects how BMI should be interpreted. As noted above, women from certain ethnic backgrounds face higher health risks at lower BMI values, meaning that standard thresholds may underestimate risk in these groups. Older women may also have lost muscle mass (a process known as sarcopenia) while gaining fat, resulting in a BMI that appears stable but masks a worsening body composition.

For these reasons, many clinicians and public health bodies, including NICE, recommend that BMI is used alongside other measures rather than in isolation. Waist circumference and waist-to-hip ratio are useful complementary tools for assessing fat distribution and associated health risk. NICE also recommends considering waist-to-height ratio: a ratio of 0.5 or above indicates increased health risk, and this measure is considered particularly useful across different ethnic groups because it adjusts for overall body size.

What other health checks should women have alongside BMI?

Women should have a range of health checks alongside BMI to build a more complete picture of their health, including waist circumference measurement, blood pressure monitoring, fasting blood glucose or HbA1c testing, and cholesterol assessment.

Waist circumference is particularly informative for assessing abdominal fat and associated health risk. NHS guidance indicates that a waist measurement above 80 cm in women is associated with increased health risk, and above 88 cm with high risk. These thresholds are based on World Health Organisation and NHS recommendations and apply to women in general; current UK guidance does not specify lower waist thresholds for women of South Asian or East Asian heritage specifically, so if you are unsure how to interpret your measurement in the context of your background, your GP can advise. NICE also recommends considering waist-to-height ratio alongside waist circumference: a ratio of 0.5 or above indicates increased risk, and 0.6 or above indicates very high risk. To calculate this, divide your waist measurement in centimetres by your height in centimetres.

Blood pressure checks are recommended regularly for all adults and are especially important for women with a BMI above 25, those who are pregnant or postpartum, and those approaching or going through the menopause. High blood pressure often has no symptoms and is a major risk factor for stroke and heart disease. In England, the NHS Health Check programme offers adults aged 40 to 74 a free check every five years, which includes blood pressure, cholesterol, blood glucose and BMI assessment.^[21]

Bone health is another consideration specific to women. Osteoporosis disproportionately affects women, particularly after the menopause, and a low BMI is an independent risk factor. Women with a BMI below 18.5, those with a history of eating disorders, or those who have experienced early menopause should discuss bone density assessment (a DEXA scan) with their GP.

For women of reproductive age, menstrual regularity can itself be a useful health indicator. Irregular or absent periods may signal hormonal imbalances, polycystic ovary syndrome (PCOS) or nutritional deficiency, none of which would be apparent from a BMI result alone. If you have concerns about any of these areas, your GP or practice nurse is the appropriate first point of contact.

Scientific References

1. Overweight and obesity in adults.
2. Calculate your body mass index (BMI).
3. Overweight and obesity management (NG246) – Identifying and assessing overweight, obesity and central adiposity.
4. Overweight and obesity management (NG246).
5. Full guideline, section 2 – Identification and classification (NG246 evidence).
6. Appendix A1: Summary of evidence from surveillance (NG246).
7. IND220 and IND221 Weight management: supporting documentation.
8. MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
9. Mounjaro | European Medicines Agency (EMA).
10. Tirzepatide | Drugs | BNF – NICE.
11. Management of overweight and obesity in adults – supporting documentation.
12. Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.
13. Infertility.
14. Fertility problems: assessment and treatment (CG156).
15. Osteoporosis | Treatment summaries – BNF – NICE.
16. Perimenopause and metabolic vulnerability: hormones, body composition and lifestyle changes.
17. Targeting insulin resistance with selected antidiabetic agents prevents menopausal associated central obesity, dysglycemia, and cardiometabolic risk.
18. Menopausal obesity and metabolic syndrome – PolSenior study.
19. Calculate your waist to height ratio.
20. Waist circumference as a measure for indicating need for weight management (Lean ME et al.).
21. NHS Health Check.
22. Sarcopenia and Sarcopenic Obesity and Mortality Among Older Adults (Benz E et al.).
23. Addressing sarcopenia – British Dietetic Association.
24. NICE waist-to-height ratio guidelines 'to have a waist <0.5' (Nevill AM et al.).

Frequently Asked Questions